{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:35:09Z","timestamp":1791477309972,"version":"4.3.4"},"reference-count":65,"publisher":"Oxford University Press (OUP)","issue":"7","funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7,1]]},"DOI":"10.1093\/ndt\/gfx080","type":"journal-article","created":{"date-parts":[[2017,4,5]],"date-time":"2017-04-05T10:27:50Z","timestamp":1491388070000},"page":"1114-1127","source":"Crossref","is-referenced-by-count":69,"title":["Clinical practice recommendations for treatment with active vitamin D analogues in children with chronic kidney disease Stages 2\u20135 and on dialysis"],"prefix":"10.1093","volume":"32","author":[{"given":"Rukshana","family":"Shroff","sequence":"first","affiliation":[{"name":"Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy","family":"Wan","sequence":"additional","affiliation":[{"name":"Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evi V.","family":"Nagler","sequence":"additional","affiliation":[{"name":"Ghent University Hospital, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevcan","family":"Bakkalo\u011flu","sequence":"additional","affiliation":[{"name":"Gazi University Hospital, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Cozzolino","sequence":"additional","affiliation":[{"name":"Ospedale San Paolo, Department of Health Sciences, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Bacchetta","sequence":"additional","affiliation":[{"name":"Hopital Femme Mere Enfant, Lyon University, Bron, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Edefonti","sequence":"additional","affiliation":[{"name":"Fondazione IRCCS C\u00e0 Granda Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantinos J.","family":"Stefanidis","sequence":"additional","affiliation":[{"name":"\"A. and P. Kyriakou\" Children\u2019s Hospital, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Vande Walle","sequence":"additional","affiliation":[{"name":"Ghent University, Utopaed, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"Ariceta","sequence":"additional","affiliation":[{"name":"Servicio de Nefrolog\u00eda Pedi\u00e1trica, Hospital Universitari Vall d'Hebron, Barcelona, Espa\u00f1a"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter","family":"Klaus","sequence":"additional","affiliation":[{"name":"KfH Pediatric Kidney Center, Marburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Haffner","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus Peter","family":"Schmitt","sequence":"additional","affiliation":[{"name":"Center for Pediatric and Adolescent Medicine, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the European Society for Paediatric Nephrology Chronic Kidney Disease Mineral and Bone Disorders and Dialysis Working Groups","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,6,1]]},"reference":[{"key":"key\n\t\t\t\t20180315024256_gfx080-B1","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s00467-010-1499-9","article-title":"The virtues of vitamin D\u2014but how much is too much?","volume":"25","author":"Shroff","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B2","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1093\/ndt\/gfs299","article-title":"The consequences of chronic kidney disease on bone metabolism and growth in children","volume":"27","author":"Bacchetta","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B3","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/MNH.0000000000000233","article-title":"Skeletal manifestations of renal disease in childhood","volume":"25","author":"Denburg","year":"2016","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.semnephrol.2012.12.017","article-title":"Chronic kidney disease: mineral and bone disorder in children","volume":"33","author":"Wesseling-Perry","year":"2013","journal-title":"Semin Nephrol"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B5","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.2215\/CJN.01330210","article-title":"Value of the new bone classification system in pediatric renal osteodystrophy","volume":"5","author":"Bakkaloglu","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B6","doi-asserted-by":"crossref","first-page":"824","DOI":"10.2215\/CJN.00330112","article-title":"The skeletal consequences of growth hormone therapy in dialyzed children: a randomized trial","volume":"8","author":"Bacchetta","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B7","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/ajt.12524","article-title":"Changes in DXA and quantitative CT measures of musculoskeletal outcomes following pediatric renal transplantation","volume":"14","author":"Tsampalieros","year":"2014","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B8","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/ki.2010.352","article-title":"Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism","volume":"79","author":"Wesseling-Perry","year":"2011","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B9","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2215\/CJN.05940611","article-title":"Early skeletal and biochemical alterations in pediatric chronic kidney disease","volume":"7","author":"Wesseling-Perry","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B10","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1681\/ASN.2015020152","article-title":"Fracture burden and risk factors in childhood CKD: results from the CKiD cohort study","volume":"27","author":"Denburg","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B11","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1046\/j.1523-1755.2000.00306.x","article-title":"Down-regulation of human osteoblast PTH\/PTHrP receptor mRNA in end-stage renal failure","volume":"58","author":"Picton","year":"2000","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B12","article-title":"Clinical practice recommendations for native vitamin D therapy in children with chronic kidney disease stages 2\u20135 and on dialysis","author":"Shroff","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B13","first-page":"CD008327","article-title":"Interventions for metabolic bone disease in children with chronic kidney disease","volume":"11","author":"Hahn","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B14","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1046\/j.1523-1755.1998.00045.x","article-title":"Intermittent calcitriol therapy in secondary hyperparathyroidism: a comparison between oral and intraperitoneal administration","volume":"54","author":"Salusky","year":"1998","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B15","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/adc.58.10.810","article-title":"Effect of low dose 1 alpha-hydroxycholecalciferol on glomerular filtration rate in moderate renal failure","volume":"58","author":"Eke","year":"1983","journal-title":"Arch Dis Child"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B16","first-page":"220","article-title":"Renal osteodystrophy in children on CAPD: a prospective trial of 1-alpha-hydroxycholecalciferol therapy","volume":"9","author":"Watson","year":"1988","journal-title":"Child Nephrol Urol"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B17","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1681\/ASN.2004100885","article-title":"Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols","volume":"16","author":"Salusky","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B18","first-page":"44","article-title":"Comparisons between oral and intraperitoneal 1,25-dihydroxyvitamin D3 therapy in children treated with peritoneal dialysis","volume":"42","author":"Jones","year":"1994","journal-title":"Clin Nephrol"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B19","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s00467-003-1091-7","article-title":"Growth in children with chronic renal failure on intermittent versus daily calcitriol","volume":"18","author":"Schmitt","year":"2003","journal-title":"Pediatr Nephrol"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B20","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/S0022-3476(05)82925-7","article-title":"Linear growth and anthropometric and nutritional measurements in children with mild to moderate renal insufficiency: a report of the Growth Failure in Children with Renal Diseases Study","volume":"116","author":"Abitbol","year":"1990","journal-title":"J Pediatr"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B21","first-page":"192","article-title":"Treatment of childhood renal osteodystrophy with calcitriol or ergocalciferol","volume":"24","author":"Hodson","year":"1985","journal-title":"Clin Nephrol"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B22","first-page":"261","article-title":"Single-dose oral calcitriol and changes of plasma 1,84iPTH in uremic children","volume":"10","author":"Klaus","year":"1994","journal-title":"Adv Perit Dial"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B23","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1046\/j.1523-1755.2000.00255.x","article-title":"No difference in intestinal strontium absorption after oral or IV calcitriol in children with secondary hyperparathyroidism. The European Study Group on Vitamin D in Children with Renal Failure","volume":"58","author":"Ardissino","year":"2000","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B24","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s00467-004-1792-6","article-title":"Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis","volume":"20","author":"Greenbaum","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B25","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1053\/j.ajkd.2007.03.008","article-title":"Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis","volume":"49","author":"Greenbaum","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B26","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/ki.2014.425","article-title":"Revisiting KDIGO clinical practice guideline on chronic kidney disease-mineral and bone disorder: a commentary from a Kidney Disease: Improving Global Outcomes controversies conference","volume":"87","author":"Ketteler","year":"2015","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B27","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B28","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ypmed.2010.08.005","article-title":"AGREE II: advancing guideline development, reporting, and evaluation in health care","volume":"51","author":"Brouwers","year":"2010","journal-title":"Prev Med"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B29","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1007\/s004670000365","article-title":"Calcitriol pulse therapy is not more effective than daily calcitriol therapy in controlling secondary hyperparathyroidism in children with chronic renal failure. European Study Group on Vitamin D in Children with Renal Failure","volume":"14","author":"Ardissino","year":"2000","journal-title":"Pediatr Nephrol"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B30","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0022-3476(05)83128-2","article-title":"A prospective, double-blind study of growth failure in children with chronic renal insufficiency and the effectiveness of treatment with calcitriol versus dihydrotachysterol. The Growth Failure in Children with Renal Diseases Investigators","volume":"124","author":"Chan","year":"1994","journal-title":"J Pediatr"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B31","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJM197802022980503","article-title":"Increased growth after long-term oral 1alpha,25-vitamin D3 in childhood renal osteodystrophy","volume":"298","author":"Chesney","year":"1978","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B32","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s11255-015-1195-6","article-title":"Comparison between paricalcitol and active non-selective vitamin D receptor activator for secondary hyperparathyroidism in chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials","volume":"48","author":"Cai","year":"2016","journal-title":"Int Urol Nephrol"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B33","doi-asserted-by":"crossref","first-page":"320560","DOI":"10.1155\/2013\/320560","article-title":"Meta-analysis: the efficacy and safety of paricalcitol for the treatment of secondary hyperparathyroidism and proteinuria in chronic kidney disease","volume":"2013","author":"Han","year":"2013","journal-title":"Biomed Res Int"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B34","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2215\/CJN.03000311","article-title":"Efficacy and safety of paricalcitol therapy for chronic kidney disease: a meta-analysis","volume":"7","author":"Cheng","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B35","doi-asserted-by":"crossref","first-page":"276","DOI":"10.5414\/CNP71276","article-title":"Comparison of intermittent intravenous and oral calcitriol in the treatment of secondary hyperparathyroidism in chronic hemodialysis patients: a meta-analysis of randomized controlled trials","volume":"71","author":"Zhou","year":"2009","journal-title":"Clin Nephol"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B36","first-page":"CD008175","article-title":"Vitamin D compounds for people with chronic kidney disease not requiring dialysis","volume":"4","author":"Palmer","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B37","first-page":"CD005633","article-title":"Vitamin D compounds for people with chronic kidney disease requiring dialysis","volume":"4","author":"Palmer","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B38","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00223-012-9619-0","article-title":"Molecular mechanisms of vitamin D action","volume":"92","author":"Haussler","year":"2013","journal-title":"Calcif Tissue Int"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B39","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1172\/JCI45890","article-title":"Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization","volume":"122","author":"Lieben","year":"2012","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B40","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jc.2012-4188","article-title":"Mineral metabolism and cortical volumetric bone mineral density in childhood chronic kidney disease","volume":"98","author":"Denburg","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B41","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2215\/CJN.04760511","article-title":"Ergocalciferol supplementation in children with CKD delays the onset of secondary hyperparathyroidism: a randomized trial","volume":"7","author":"Shroff","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B42","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ki.1994.380","article-title":"Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy","volume":"46","author":"Goodman","year":"1994","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B43","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1542\/peds.68.4.559","article-title":"Effects of 1,25-dihydroxyvitamin-D3 on renal function, mineral balance, and growth in children with severe chronic renal failure","volume":"68","author":"Chan","year":"1981","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B44","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1046\/j.1523-1755.1998.00724.x","article-title":"Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD","volume":"53","author":"Kuizon","year":"1998","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B45","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B46","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.abb.2011.11.011","article-title":"Bone effects of vitamin D - discrepancies between in vivo and in vitro studies","volume":"523","author":"Suda","year":"2012","journal-title":"Arch Biochem Biophys"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B47","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/ki.2010.316","article-title":"The bone and mineral disorder of children undergoing chronic peritoneal dialysis","volume":"78","author":"Borzych","year":"2010","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B48","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1111\/j.1523-1755.2005.00339.x","article-title":"Parathyroid hormone and growth in children with chronic renal failure","volume":"67","author":"Waller","year":"2005","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B49","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1681\/ASN.2006121397","article-title":"Mineral metabolism and vascular damage in children on dialysis","volume":"18","author":"Shroff","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B50","doi-asserted-by":"crossref","DOI":"10.1007\/s00467-017-3579-6","article-title":"Paricalcitol is effective and well-tolerated in children with stages 3 to 5 chronic kidney disease","author":"Webb","year":"2017 ( )","journal-title":"Pediatr Nephrol"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B51","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/nep.12505","article-title":"The effect of active vitamin d on cardiovascular outcomes in predialysis chronic kidney diseases: a systematic review and meta-analysis","volume":"20","author":"Li","year":"2015","journal-title":"Nephrology (Carlton)"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B52","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s004670000352","article-title":"Implications of intermittent calcitriol therapy on growth and secondary hyperparathyroidism","volume":"14","author":"Salusky","year":"2000","journal-title":"Pediatr Nephrol"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B53","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1177\/089686080702700615","article-title":"Intraperitoneal calcitriol in infants on peritoneal dialysis","volume":"27","author":"Cano","year":"2007","journal-title":"Perit Dial Int"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B54","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00467-012-2324-4","article-title":"Bone disease in pediatric chronic kidney disease","volume":"28","author":"Wesseling-Perry","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B55","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1373\/clinchem.2007.085506","article-title":"An N-terminal molecular form of parathyroid hormone (PTH) distinct from hPTH(1\u200984) is overproduced in parathyroid carcinoma","volume":"53","author":"Rubin","year":"2007","journal-title":"Clin Chem"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B56","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0085-2538(15)47156-X","article-title":"A novel mechanism for skeletal resistance in uremia","volume":"58","author":"Slatopolsky","year":"2000","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B57","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/ki.1994.31","article-title":"Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD\/CCPD","volume":"45","author":"Salusky","year":"1994","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B58","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1681\/ASN.V3121938","article-title":"Renal bone disease in pediatric and young adult patients on hemodialysis in a children's hospital","volume":"3","author":"Mathias","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B59","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1651-2227.2000.tb00361.x","article-title":"Bone biopsy results and serum bone turnover parameters in uremic children","volume":"89","author":"Ziolkowska","year":"2000","journal-title":"Acta Paediatr"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B60","first-page":"S1","article-title":"National Kidney Foundation. K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42 (4 Suppl 3)","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B61","first-page":"S1","article-title":"Kidney Disease: Improving Global Outcomes CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"113","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B62","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00467-005-2082-7","article-title":"Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines","volume":"21","author":"Klaus","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B63","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s00467-008-0838-6","article-title":"Bone histomorphometry in children prior to commencing renal replacement therapy","volume":"23","author":"Waller","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B64","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00467-012-2270-1","article-title":"Searching the optimal PTH target range in children undergoing peritoneal dialysis: new insights from international cohort studies","volume":"28","author":"Haffner","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"key\n\t\t\t\t20180315024256_gfx080-B65","doi-asserted-by":"crossref","first-page":"e0147347","DOI":"10.1371\/journal.pone.0147347","article-title":"Effect of vitamin D receptor activators on glomerular filtration rate: a meta-analysis and systematic review","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/32\/7\/1114\/24363822\/gfx080.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T06:23:40Z","timestamp":1658903020000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/32\/7\/1114\/3860033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,1]]},"references-count":65,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,6,1]]},"published-print":{"date-parts":[[2017,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfx080","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,7]]},"published":{"date-parts":[[2017,6,1]]}}}